Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling

QR Code

Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling

Abstract TGFβ signaling plays crucial role during development and cancer, however the role for TGFβ signaling in regulating the noncoding part of the human genome in triple negative breast cancer (TNBC) is still being unraveled. Herein, we provide the transcriptional landscape of TNBC in response to...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Radhakrishnan Vishnubalaji, Nehad M. Alajez
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2021
Sujets:	Medicine R Science Q
Accès en ligne:	https://doaj.org/article/70b0fdd9d04744d38c5c5b3d07a3f568
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast Cancer
par: Hibah Shaath, et autres
Publié: (2021)

Convergence of TGFβ and BMP signaling in regulating human bone marrow stromal cell differentiation
par: Mona Elsafadi, et autres
Publié: (2019)

Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms
par: Manvi Sharma, et autres
Publié: (2021)

EGR1 and RXRA transcription factors link TGF-β pathway and CCL2 expression in triple negative breast cancer cells
par: Alisa M. Gorbacheva, et autres
Publié: (2021)

Implications of TGFβ Signaling and CDK Inhibition for the Treatment of Breast Cancer
par: Joseph T. Decker, et autres
Publié: (2021)

Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling
par: Tiffany Scully, et autres
Publié: (2021)

Triple negative breast cancer: an Indian perspective
par: Akhtar M, et autres
Publié: (2015)

SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis
par: Xiaolong Tang, et autres
Publié: (2017)

TGFβ promotes fibrosis by MYST1-dependent epigenetic regulation of autophagy
par: Ariella Zehender, et autres
Publié: (2021)

A triple negative breast cancer: what it is not!
par: Katakkar SB
Publié: (2012)

TGF-β Signaling and Resistance to Cancer Therapy
par: Maoduo Zhang, et autres
Publié: (2021)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
par: Swanner J, et autres
Publié: (2015)

Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits
par: Chiara Giacomelli, et autres
Publié: (2021)

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
par: Wen-Hung Kuo, et autres
Publié: (2012)

BRCA2 mutations and triple-negative breast cancer.
par: Peter Meyer, et autres
Publié: (2012)

Triple-negative breast cancer: treatment challenges and solutions
par: Collignon J, et autres
Publié: (2016)

Opportunities for metastatic triple negative breast cancer therapy
par: Inna P. Ganshina, et autres
Publié: (2021)

Antiangiogenic therapy for breast cancer with triple negative phenotype
par: Inna P. Ganshina, et autres
Publié: (2021)

LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women
par: Torres-Luquis O, et autres
Publié: (2018)

Molecular-Genetic Portrait of Breast Cancer with Triple Negative Phenotype
par: Marina K. Ibragimova, et autres
Publié: (2021)

MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
par: Dawid Mehlich, et autres
Publié: (2021)

Molecular heterogeneity in adjacent cells in triple-negative breast cancer
par: Huebschman ML, et autres
Publié: (2015)

Disulfiram Improves the Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Expression via Epigenetically Reactivation of IRF7 in Triple Negative Breast Cancer
par: Xin Zheng, et autres
Publié: (2021)

Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells.
par: Rajeshwari Mehta, et autres
Publié: (2013)

Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
par: Paolo Peterlongo, et autres
Publié: (2021)

Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment
par: L. E. Anselmino, et autres
Publié: (2021)

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
par: Gábor Cserni, et autres
Publié: (2021)

TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis
par: Oihana Iriondo, et autres
Publié: (2018)

A new immunochemical strategy for triple-negative breast cancer therapy
par: Chih-Wei Lin, et autres
Publié: (2021)

Peptide density targets and impedes triple negative breast cancer metastasis
par: Daxing Liu, et autres
Publié: (2018)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
par: Fleisher B, et autres
Publié: (2016)

Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
par: Inna P. Ganshina, et autres
Publié: (2021)

Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
par: Alberto Aranza-Martínez, et autres
Publié: (2021)

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
par: Anna E. M. Bastiaansen, et autres
Publié: (2020)

Co-dependency for MET and FGFR1 in basal triple-negative breast cancers
par: Vanessa Y. C. Sung, et autres
Publié: (2021)

Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients.
par: Katsuhiro Yoshikawa, et autres
Publié: (2021)

Expression of LGR5 in mammary myoepithelial cells and in triple-negative breast cancers
par: Hyun Ju Lee, et autres
Publié: (2021)

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
par: Corey Speers, et autres
Publié: (2017)

Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment
par: da Silva JL, et autres
Publié: (2021)

Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment
par: Bowen Gao, et autres
Publié: (2021)